Cell Biotech Co., Ltd. (KOSDAQ:A049960) announces a share repurchase program. Under the program, the company will repurchase up to KRW 5,000 million worth of its shares pursuant to a trust contract with Hana Financial Investment Co., Ltd. The purpose of the program is to improve shareholder value and stabilize the stock price. The program is valid until August 18, 2022.

As of February 18, 2022, the company had 2,328,381 shares in treasury within scope available for dividend and no shares in treasury through other repurchase.